Internal cap-initiated translation for efficient protein production from circular mRNA – Nature Biotechnology
Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).
Google Scholar
Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–416 (2021).
Google Scholar
Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586–1600 (2022).
Google Scholar
Sparmann, A. & Vogel, J. RNA-based medicine: from molecular mechanisms to therapy. EMBO J. 42, e114760 (2023).
Google Scholar
Liu, C. et al. mRNA-based cancer therapeutics. Nat. Rev. Cancer 23, 526–543 (2023).
Google Scholar
Wesselhoeft, R. A. et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol. Cell 74, 508–520 (2019).
Google Scholar
Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).
Google Scholar
Meganck, R. M. et al. Tissue-dependent expression and translation of circular RNAs with recombinant AAV vectors in vivo. Mol. Ther. Nucleic Acids 13, 89–98 (2018).
Google Scholar
Meganck, R. M. et al. Engineering highly efficient backsplicing and translation of synthetic circRNAs. Mol. Ther. Nucleic Acids 23, 821–834 (2021).
Google Scholar
Qu, L. et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell 185, 1728–1744 (2022).
Google Scholar
Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262–272 (2023).
Google Scholar
Unti, M. J. & Jaffrey, S. R. Highly efficient cellular expression of circular mRNA enables prolonged protein expression. Cell Chem. Biol. 31, 163–176 (2024).
Google Scholar
Amaya, L. et al. Circular RNA vaccine induces potent T cell responses. Proc. Natl Acad. Sci. USA 120, e2302191120 (2023).
Google Scholar
Pelletier, J., Schmeing, T. M. & Sonenberg, N. The multifaceted eukaryotic cap structure. Wiley Interdiscip. Rev. RNA 12, e1636 (2021).
Google Scholar
Pelletier, J. & Sonenberg, N. The organizing principles of eukaryotic ribosome recruitment. Annu. Rev. Biochem. 88, 307–335 (2019).
Google Scholar
Wang, Y. & Wang, Z. F. Efficient backsplicing produces translatable circular mRNAs. RNA 21, 172–179 (2015).
Google Scholar
Yang, Y. et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 27, 626–641 (2017).
Google Scholar
He, P. C. & He, C. m6A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 40, e105977 (2021).
Google Scholar
Hellen, C. U. T. IRES-induced conformational changes in the ribosome and the mechanism of translation initiation by internal ribosomal entry. Biochim. Biophys. Acta 1789, 558–570 (2009).
Google Scholar
Hall, M. P. et al. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem. Biol. 7, 1848–1857 (2012).
Google Scholar
Abe, N. et al. Complete chemical synthesis of minimal messenger RNA by efficient chemical capping reaction. ACS Chem. Biol. 17, 1308–1314 (2022).
Google Scholar
Ellipilli, S., Phillips, J. D. & Heemstra, J. M. Synthesis of comb-shaped DNA using a non-nucleosidic branching phosphoramidite. Org. Biomol. Chem. 16, 4659–4664 (2018).
Google Scholar
Abe, N. et al. Rolling circle translation of circular RNA in living human cells. Sci. Rep. 5, 16435 (2015).
Google Scholar
Karikó, K., Buckstein, M., Ni, H. P. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).
Google Scholar
Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008).
Google Scholar
Kao, C., Zheng, M. & Rüdisser, S. A simple and efficient method to reduce nontemplated nucleotide addition at the 3′ terminus of RNAs transcribed by T7 RNA polymerase. RNA 5, 1268–1272 (1999).
Google Scholar
Santoro, S. W. & Joyce, G. F. A general purpose RNA-cleaving DNA enzyme. Proc. Natl Acad. Sci. USA 94, 4262–4266 (1997).
Google Scholar
Gamper, H. et al. Synthesis of long RNA with a site-specific modification by enzymatic splint ligation. Preprint at bioRxiv https://doi.org/10.1101/2022.09.17.508400 (2022).
Palmenberg, A. C., Rathe, J. A. & Liggett, S. B. Analysis of the complete genome sequences of human rhinovirus. J. Allergy Clin. Immunol. 125, 1190–1199 (2010).
Google Scholar
Bordeleau, M. E. et al. Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat. Chem. Biol. 2, 213–220 (2006).
Google Scholar
Steinberger, J. et al. Identification and characterization of hippuristanol-resistant mutants reveals eIF4A1 dependencies within mRNA 5′ leader regions. Nucleic Acids Res. 48, 9521–9537 (2020).
Google Scholar
Abdullah, S. W., Wu, J. E., Wang, X. F., Guo, H. C. & Sun, S. Q. Advances and breakthroughs in IRES-directed translation and replication of picornaviruses. mBio 14, e0035823 (2023).
Google Scholar
Bernstein, P., Peltz, S. W. & Ross, J. The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol. Cell. Biol. 9, 659–670 (1989).
Google Scholar
Deo, R. C., Bonanno, J. B., Sonenberg, N. & Burley, S. K. Recognition of polyadenylate RNA by the poly(A)-binding protein. Cell 98, 835–845 (1999).
Google Scholar
Henderson, J. M. et al. Cap 1 messenger RNA synthesis with co-transcriptional CleanCap(®) analog by in vitro transcription. Curr. Protoc. 1, e39 (2021).
Google Scholar
Zeng, C., Zhang, C., Walker, P. G. & Dong, Y. Formulation and delivery technologies for mRNA vaccines. Curr. Top. Microbiol. Immunol. 440, 71–110 (2022).
Google Scholar
Husseini, R. A., Abe, N., Hara, T., Abe, H. & Kogure, K. Use of iontophoresis technology for transdermal delivery of a minimal mRNA vaccine as a potential melanoma therapeutic. Biol. Pharm. Bull. 46, 301–308 (2023).
Google Scholar
Imani, S., Tagit, O. & Pichon, C. Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact. NPJ Vaccines 9, 14 (2024).
Google Scholar
Puttaraju, M. et al. Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome. Nat. Med. 27, 526–535 (2021).
Google Scholar
Lu, Z. J. & Mathews, D. H. Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design. Nucleic Acids Res. 36, 3738–3745 (2008).
Google Scholar
Egli, M. & Manoharan, M. Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic Acids Res. 51, 2529–2573 (2023).
Google Scholar
Lesiak, K., Khamnei, S. & Torrence, P. F. 2′,5′-Oligoadenylate:antisense chimeras. Synthesis and properties. Bioconjugate Chem. 4, 467–472 (1993).
Google Scholar
Passmore, L. A. & Coller, J. Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression. Nat. Rev. Mol. Cell Biol. 23, 93–106 (2022).
Google Scholar
Picard-Jean, F. et al. 2′-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO. PLoS ONE 13, e0193804 (2018).
Google Scholar
Despic, V. & Jaffrey, S. R. mRNA ageing shapes the Cap2 methylome in mammalian mRNA. Nature 614, 358–366 (2023).
Google Scholar
Koshkin, A. A. et al. LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron 54, 3607–3630 (1998).
Google Scholar
Obika, S. et al. Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides. Tetrahedron Lett. 39, 5401–5404 (1998).
Google Scholar
Costello, A., Lao, N. T., Barron, N. & Clynes, M. Continuous translation of circularized mRNA improves recombinant protein titer. Metab. Eng. 52, 284–292 (2019).
Google Scholar
Mattick, J. S. et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 24, 430–447 (2023).
Google Scholar
Yu, X., Zheng, H. Y., Chan, M. T. V. & Wu, W. K. K. HULC: an oncogenic long non-coding RNA in human cancer. J. Cell. Mol. Med. 21, 410–417 (2017).
Google Scholar
Zhao, Y. et al. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol. Rep. 31, 358–364 (2014).
Google Scholar
Joseph, R., Srivastava, O. P. & Pfister, R. R. Downregulation of β-actin and its regulatory gene HuR affect cell migration of human corneal fibroblasts. Mol. Vis. 20, 593–605 (2014).
Google Scholar
Morais, P., Adachi, H. & Yu, Y. T. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front. Cell Dev. Biol. 9, 789427 (2021).
Google Scholar
Bathula, N. V. et al. Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity. J. Control. Release 374, 28–38 (2024).
Google Scholar
Anderluzzi, G. et al. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency. J. Control. Release 342, 388–399 (2022).
Google Scholar
Münter, R., Christensen, E., Andresen, T. L. & Larsen, J. B. Studying how administration route and dose regulates antibody generation against LNPs for mRNA delivery with single-particle resolution. Mol. Ther. Methods Clin. Dev. 29, 450–459 (2023).
Google Scholar
Darrah, P. A. et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature 577, 95–102 (2020).
Google Scholar
Leppek, K., Das, R. & Barna, M. Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them. Nat. Rev. Mol. Cell Biol. 19, 158–174 (2018).
Google Scholar
Paek, K. Y., Park, S. M., Hong, K. Y. & Jang, S. K. Cap-dependent translation without base-by-base scanning of an messenger ribonucleic acid. Nucleic Acids Res. 40, 7541–7551 (2012).
Google Scholar
Carrieri, C. et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 491, 454–457 (2012).
Google Scholar
Pierattini, B. et al. SINEUP non-coding RNA activity depends on specific N6-methyladenosine nucleotides. Mol. Ther. Nucleic Acids 32, 402–414 (2023).
Google Scholar
Sharma, H. et al. Decryption of sequence, structure, and functional features of SINE repeat elements in SINEUP non-coding RNA-mediated post-transcriptional gene regulation. Nat. Commun. 15, 1400 (2024).
Google Scholar
Cao, Y. et al. RNA-based translation activators for targeted gene upregulation. Nat. Commun. 14, 6827 (2023).
Google Scholar
Cao, X. A., Zhang, Y. Y., Ding, Y. L. & Wan, Y. Identification of RNA structures and their roles in RNA functions. Nat. Rev. Mol. Cell Biol. 25, 784–801 (2024).
Google Scholar
Sun, L. et al. RNA structure maps across mammalian cellular compartments. Nat. Struct. Biol. 26, 322–330 (2019).
Google Scholar
Liu, C. X. & Chen, L. L. Circular RNAs: characterization, cellular roles, and applications. Cell 185, 2016–2034 (2022).
Google Scholar
Diallo, L. H. et al. How are circRNAs translated by non-canonical initiation mechanisms? Biochimie 164, 45–52 (2019).
Google Scholar
Legnini, I. et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol. Cell 66, 22–37 (2017).
Google Scholar
Pitsch, S., Weiss, P. A., Jenny, L., Stutz, A. & Wu, X. L. Reliable chemical synthesis of oligoribonucleotides (RNA) with 2′-O-[(triisopropylsilyl)oxy]methyl(2′-O-tom)-protected phosphoramidites. Helv. Chim. Acta 84, 3773–3795 (2001).
Google Scholar
Ototake, M. et al. Development of hydrophobic tag purifying monophosphorylated RNA for chemical synthesis of capped mRNA and enzymatic synthesis of circular mRNA. Nucleic Acids Res. 52, 12141–12157 (2024).
Google Scholar
Inagaki, M. et al. Cap analogs with a hydrophobic photocleavable tag enable facile purification of fully capped mRNA with various cap structures. Nat. Commun. 14, 2657 (2023).
Google Scholar
